Skip to main content

Treace Medical Concepts, Inc.

TMCI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001630627

In the last 90 days, Treace Medical Concepts, Inc. insiders filed 1 open-market purchase and 0 sales; 116 institutions reported holding it in 13F filings for Q2 2026, worth $126.8M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Treace Medical Concepts, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of TMCI: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders125119−6
Shares38.4M38.8M+390.2K (+1.0%)
Value$226.1M$260.3M+$34.2M (+15.1%)

New holders (15)

Institutions that held Treace Medical Concepts, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to TMCI in Q3 2025
InstitutionSharesValue% of portfolio
Opaleye Management Inc.702,245$4.71M0.67%
Acuitas Investments, LLC301,100$2.02M1.30%
Moore Capital Management, LP147,607$990.4K0.02%
Palumbo Wealth Management LLC20,022$134.3K0.04%
Roundview Capital LLC16,500$110.7K0.01%
Susquehanna Portfolio Strategies, LLC13,925$93.4K0.00%
Mercer Global Advisors Inc12,916$86.7K0.00%
Rockefeller Capital Management L.P.8,360$56.1K0.00%
SRS Capital Advisors, Inc.3,564$23.9K0.00%
State of Alaska, Department of Revenue3,343$22.0K0.00%
Optiver Holding B.V.818$5.49K0.00%
Quadrant Capital Group LLC784$5.26K0.00%
Stephens Consulting, LLC473$3.17K0.00%
Davis Capital Management250$1.68K0.00%
Sunbelt Securities, Inc.20$1340.00%

Sold out (21)

Institutions that held Treace Medical Concepts, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.